Recent research has unveiled that Mic-628 operates by binding to CRY1, a protein that typically inhibits the activity of clock genes. This binding promotes the formation of a complex known as CLOCK-BMAL1-CRY1-Mic-628. Once this complex is established, it activates Per1 by targeting a specific DNA region referred to as a "dual E-box." This process effectively alters the timing of the brain's primary clock located in the suprachiasmatic nucleus (SCN), as well as the clocks present in various organs, including the lungs. Importantly, these adjustments in timing occur simultaneously and are independent of the timing of the drug administration.
Accelerated Recovery from Jet Lag Observed in Animal Studies
To assess the practical implications, researchers utilized a mouse model to simulate jet lag by advancing the light-dark cycle by six hours. Mice that received a single dose of Mic-628 adapted to the new schedule significantly quicker, completing the adjustment in just four days as opposed to seven. Further analysis revealed that this consistent forward shift is facilitated by a feedback loop involving the PER1 protein, which aids in stabilizing the clock adjustment.
The Challenge of Advancing the Body Clock
Shifting to earlier schedules, such as traveling east across time zones or working night shifts, necessitates the body clock to advance. This type of adjustment is generally more gradual and stressful for the body compared to delaying the clock. Common methods like light exposure and melatonin are highly dependent on precise timing and often yield inconsistent results. In contrast, Mic-628 reliably advances the clock irrespective of the timing of administration, offering a novel drug-based strategy for resetting circadian rhythms.
Future Directions for Mic-628
The research team intends to further investigate Mic-628 to enhance understanding of its safety and efficacy through additional animal studies and human trials. Given its ability to consistently advance the body clock via a well-defined biological mechanism, Mic-628 has the potential to become a pioneering "smart drug" for mitigating jet lag, addressing sleep disturbances related to shift work, and tackling other issues stemming from circadian misalignment.
The results were published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
